Patrizio Mattei

1.6k total citations · 1 hit paper
24 papers, 980 citations indexed

About

Patrizio Mattei is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Patrizio Mattei has authored 24 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Patrizio Mattei's work include Neuropeptides and Animal Physiology (7 papers), Diabetes Treatment and Management (6 papers) and Receptor Mechanisms and Signaling (5 papers). Patrizio Mattei is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Diabetes Treatment and Management (6 papers) and Receptor Mechanisms and Signaling (5 papers). Patrizio Mattei collaborates with scholars based in Switzerland, United States and Germany. Patrizio Mattei's co-authors include Bernd Kuhn, Michael Hennig, Donald Hilvert, Peter Kast, Jens‐Uwe Peters, Patrick Schnider, François Diederich, Manfred Kansy, Urs Sprecher and Christoph Ullmer and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Kidney International.

In The Last Decade

Patrizio Mattei

24 papers receiving 940 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new antibiotic traps lipopolysaccharide in its intermembrane transporter

2024 74 citations Karanbir S. Pahil, Morgan S. A. Gilman et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrizio Mattei Switzerland	16	462	201	175	167	135	24	980
Wen‐Xu Hong China	20	759 1.6×	180 0.9×	92 0.5×	222 1.3×	79 0.6×	77	1.5k
Roberto Artali Italy	24	698 1.5×	255 1.3×	84 0.5×	168 1.0×	35 0.3×	70	1.2k
Mario Cardozo United States	18	773 1.7×	552 2.7×	233 1.3×	171 1.0×	67 0.5×	31	1.4k
Owen B. Wallace United States	16	689 1.5×	403 2.0×	405 2.3×	131 0.8×	35 0.3×	27	1.6k
Ted W. Johnson United States	18	790 1.7×	395 2.0×	214 1.2×	156 0.9×	169 1.3×	28	1.6k
Terry W. Moore United States	23	1.0k 2.2×	402 2.0×	80 0.5×	142 0.9×	76 0.6×	61	1.6k
Darren Fayne Ireland	19	406 0.9×	456 2.3×	255 1.5×	95 0.6×	39 0.3×	52	1.1k
Paul Rowland United Kingdom	17	712 1.5×	96 0.5×	187 1.1×	180 1.1×	36 0.3×	29	1.3k
William M. Atkins United States	21	994 2.2×	83 0.4×	216 1.2×	458 2.7×	84 0.6×	43	1.9k
Jung-Ja P. Kim United States	10	758 1.6×	47 0.2×	105 0.6×	192 1.1×	80 0.6×	10	1.3k

Countries citing papers authored by Patrizio Mattei

Since Specialization

Citations

This map shows the geographic impact of Patrizio Mattei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizio Mattei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizio Mattei more than expected).

Fields of papers citing papers by Patrizio Mattei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizio Mattei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizio Mattei. The network helps show where Patrizio Mattei may publish in the future.

Co-authorship network of co-authors of Patrizio Mattei

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizio Mattei. A scholar is included among the top collaborators of Patrizio Mattei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizio Mattei. Patrizio Mattei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Rainer E., Alexander L. Satz, Daniel Hunziker, et al.. (2025). Optimization of a DNA encoded library derived autotaxin inhibitor hit to a potent in vivo LPA lowering quinazolinone compound with a non‑zinc binding mode. Bioorganic & Medicinal Chemistry Letters. 123. 130221–130221. 3 indexed citations

Pahil, Karanbir S., Morgan S. A. Gilman, Vadim Baidin, et al.. (2024). A new antibiotic traps lipopolysaccharide in its intermembrane transporter. Nature. 625(7995). 572–577. 74 indexed citations breakdown →

Hunziker, Daniel, Sabrina Reinehr, Natalie Wagner, et al.. (2022). Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor. Frontiers in Pharmacology. 12. 699535–699535. 8 indexed citations

Hunziker, Daniel, et al.. (2019). Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(1). 165560–165560. 34 indexed citations

Reutlinger, Michael, et al.. (2018). Understanding Molecular Drivers of Melanin Binding To Support Rational Design of Small Molecule Ophthalmic Drugs. Journal of Medicinal Chemistry. 61(22). 10106–10115. 27 indexed citations

Kuhn, Bernd, Wolfgang Guba, Jérôme Hert, et al.. (2016). A Real-World Perspective on Molecular Design. Journal of Medicinal Chemistry. 59(9). 4087–4102. 80 indexed citations

Dehmlow, Henrietta, Stephan Bachmann, Caterina Bissantz, et al.. (2013). Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonists. Bioorganic & Medicinal Chemistry Letters. 23(16). 4627–4632. 13 indexed citations

Mayweg, A., Urs Hofer, Patrick Schnider, et al.. (2011). ROCK: the Roche medicinal chemistry knowledge application – design, use and impact. Drug Discovery Today. 16(15-16). 691–696. 15 indexed citations

Sayyed, Sufyan G., Mi Heon Ryu, Onkar P. Kulkarni, et al.. (2011). An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney International. 80(1). 68–78. 99 indexed citations

10.

Peters, Jens‐Uwe, Patrick Schnider, Patrizio Mattei, & Manfred Kansy. (2009). Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds. ChemMedChem. 4(4). 680–686. 109 indexed citations

11.

Mattei, Patrizio, Markus Boehringer, Holger Fischer, et al.. (2009). Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 20(3). 1109–1113. 54 indexed citations

12.

Boehringer, Markus, Holger Fischer, Michael Hennig, et al.. (2009). Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1106–1108. 38 indexed citations

13.

Lübbers, Thomas, Luca Gobbi, Michael Hennig, et al.. (2007). 1,3-Disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(11). 2966–2970. 30 indexed citations

14.

Kuhn, Bernd, Michael Hennig, & Patrizio Mattei. (2007). Molecular Recognition of Ligands in Dipeptidyl Peptidase IV. Current Topics in Medicinal Chemistry. 7(6). 609–620. 68 indexed citations

15.

Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Aminothiazole Derivatives as Neuropeptide Y5 Receptor Ligands: Finding the Balance between Affinity and Physicochemical Properties. ChemMedChem. 1(1). 45–48. 10 indexed citations

16.

Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters. 15(14). 3446–3449. 10 indexed citations

17.

Mattei, Patrizio, Peter Kast, & Donald Hilvert. (1999). Bacillus subtilis chorismate mutase is partially diffusion‐controlled. European Journal of Biochemistry. 261(1). 25–32. 56 indexed citations

18.

Gustin, Darin J., Patrizio Mattei, Peter Kast, et al.. (1999). Heavy Atom Isotope Effects Reveal a Highly Polarized Transition State for Chorismate Mutase. Journal of the American Chemical Society. 121(8). 1756–1757. 76 indexed citations

19.

Mattei, Patrizio & François Diederich. (1996). Ein Flavo‐Thiazolio‐Cyclophan als funktionsfähiges Modell für die Pyruvat‐Oxidase. Angewandte Chemie. 108(12). 1434–1437. 5 indexed citations

20.

Mattei, Patrizio & François Diederich. (1996). A Flavo‐Thiazolio‐Cyclophane as a Functional Model for Pyruvate Oxidase. Angewandte Chemie International Edition in English. 35(12). 1341–1344. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact